Jose Luis Vázquez-Barquero, MD, PhD
- 3Articles
- 11KReads1
- 2006–2007Active
- 12Collaborators
About
Jose Luis Vázquez-Barquero, MD, PhD, has published research focused on the treatment of first-episode psychosis, particularly examining metabolic changes and weight gain associated with antipsychotic medications such as haloperidol, olanzapine, and risperidone. His work includes clinical trials comparing these drugs for acute treatment and investigating behavioral interventions to mitigate side effects. His studies contribute to the understanding of psychopharmacology within neurology.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
